Related Experiment Video
Updated: May 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]
Tjerk Wiersma1, Yvo M Smulders, Coen D A Stehouwer
1Nederlands Huisartsen Genootschap, afd. Richtlijnontwikkeling en Wetenschap, Utrecht, the Netherlands. T.Wiersma@nhg.org
Insights
New cardiovascular risk tables incorporate Dutch morbidity data to guide treatment decisions. The study also addresses risk factors like sedentary lifestyle, high BMI, and specific patient groups, alongside updated hypertension and statin recommendations.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Abstract:
The decision whether to treat individuals not previously known to have cardiovascular disease is based on a new risk table in which Dutch research data on morbidity have been incorporated. An explanation of the roles of additional risk factors ignored in the cardiovascular risk function, such as a sedentary lifestyle and a high BMI, is provided. A method for estimating the cardiovascular risk in patients with diabetes mellitus and rheumatoid arthritis has been developed. New recommendations concerning the measurement of blood pressure at home and in the ambulatory setting have been formulated. The recommendations for the choice of antihypertensive drugs have been revised. The recommendations on handling therapy-resistant hypertension are provided. Recommendations for choosing statins based on a current cost-effectiveness analysis are provided.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications